General information

From April 1, 2023, the use of Jardiance® (empagliflozin) in patients with chronic heart failure regardless of ejection fraction (HFrEF, HFmrEF and HFpEF) is regularly reimbursed through the health insurance. Due to the extension of the reimbursement of Jardiance®(empagliflozin), the reimbursement scheme by TBR Nederland is lifted. The Pharmacy or patient can declare dispensations between the period March 3, 2022 to April 1, 2023 up to September 1, 2023 at the latest.

For a complete reimbursment overview of Jardiance® 10 mg, click here

Dose Jardiance® 10 mg
Type Pill
Active ingredient EMPAGLIFLOZIN



Jardiance®(empagliflozin) 10 mg was fully reimbursed from March 3, 2022 to April 1, 2023 through TBR Nederland. Issues that have taken place during this period can be submitted until September 1, 2023 at the latest.

Who can submit a claim

1. Patients or their carer can claim the costs for Jardiance® 10 mg online or by post.                          

2. Pharmacists can only claim this medicine online, on behalf of the patient.

From when till when can you submit a claim

Submit a claim online

Patients can claim online and will receive their reimbursement within 5 working days.

Read our tips on how to submit a claim online

Login & Submit a Claim          Open an Online Account


Submit a claim by post

Patients can claim by post and will receive their reimbursement within 15 working days.

Read our tips on how to submit your claim by post

Please mail the Claim Form and attachments to:

TBR Nederland
Postbus 8011
1180 LA Amstelveen 


Check your medicine expenses

Quickly check the maximum contribution you have to pay for your medicine

Check Medicine Expenses


Select your medicine

You are currently offline. Some pages or content may fail to load.